# Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation: Erratum

**Authors:** Yun-Xin Lu, Qi-Nian Wu, Dong-liang Chen, Le-Zong Chen, Zi-Xian Wang, Chao Ren, Hai-yu Mo, Ya Chen, Hui Sheng, Ying-Nan Wang, Yun Wang, Jia-Huan Lu, De-shen Wang, Zhao-lei Zeng, Feng Wang, Feng-Hua Wang, Yu-Hong Li, Huai-Qiang Ju, Rui-Hua Xu

PMC · DOI: 10.7150/thno.114259 · Theranostics · 2025-04-19

## Full-text entities

- **Genes:** SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}
- **Diseases:** Gastric Cancer (MESH:D013274)
- **Chemicals:** Ascorbate (MESH:D001205), Oxaliplatin (MESH:D000077150), Erratum (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12068285/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12068285/full.md

---
Source: https://tomesphere.com/paper/PMC12068285